Mural Oncology (MURA) Institutional Ownership $3.35 -0.02 (-0.59%) (As of 11/22/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Mural Oncology (NASDAQ:MURA)CurrentInstitutional OwnershipPercentage80.21%Number ofInstitutional Buyers(last 12 months)17TotalInstitutional Inflows(last 12 months)$9.72MNumber ofInstitutional Sellers(last 12 months)6TotalInstitutional Outflows(last 12 months)$1.25M Get MURA Insider Trade Alerts Want to know when executives and insiders are buying or selling Mural Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data MURA Institutional Buying and Selling by Quarter Ad Insiders Exposed917 Trades… Zero Losses?As you likely know, the “Trump bump” launched stocks to record highs after he secured his second reelection bid. Now, Trump and his team are coming to gut government regulation – and it’s going to create some incredible market opportunities. But while the masses chase large-cap tech and so-called AI stocks, a small circle of traders are using a strange but tactical method to find a pool of “hidden Trump trades.”Go here to see how you can start accessing these opportunities today Mural Oncology Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/16/2024 Geode Capital Management LLC190,056$595K0.0%+2.6%1.115% 11/15/2024 RBF Capital LLC359,900$1.13M0.1%-7.3%2.112% 11/15/2024 Point72 Asset Management L.P.108,715$340K0.0%N/A0.638% 11/15/2024 Centiva Capital LP203,706$638K0.0%-9.3%1.195% 11/15/2024 Point72 Asia Singapore Pte. Ltd.12,574$39K0.0%-52.8%0.074% 11/14/2024 Verition Fund Management LLC340,000$1.06M0.0%-33.4%1.996% Get the Latest News and Ratings for MURA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Mural Oncology and its competitors with MarketBeat's FREE daily newsletter. 11/13/2024 BNP Paribas Financial Markets28,048$88K0.0%-71.0%0.165% 11/13/2024 FMR LLC20,580$64K0.0%+124.7%0.121% 11/9/2024 Primecap Management Co. CA140,045$438K0.0%-40.5%0.822% 11/8/2024 Commerce Bank12,423$39K0.0%N/A0.073% 9/16/2024 Cubist Systematic Strategies LLC31,243$98K0.0%N/A0.185% 9/16/2024 Point72 Asia Singapore Pte. Ltd.26,642$84K0.0%N/A0.157% 8/15/2024 Armistice Capital LLC1,688,000$5.30M0.1%N/A9.974% 8/15/2024 Point72 Asia Singapore Pte. Ltd.26,642$84K0.0%N/A0.157% 8/14/2024 Squarepoint Ops LLC167,644$526K0.0%N/A0.991% 8/14/2024 Cubist Systematic Strategies LLC31,243$98K0.0%N/A0.185% 8/13/2024 Canada Pension Plan Investment Board22,360$70K0.0%N/A0.132% 8/9/2024 Primecap Management Co. CA235,551$740K0.0%N/A1.392% 8/9/2024 Renaissance Technologies LLC232,100$729K0.0%N/A1.371% 8/9/2024 Dimensional Fund Advisors LP22,563$71K0.0%N/A0.133% 8/8/2024 Nicollet Investment Management Inc.98,016$308K0.1%N/A0.579% 8/6/2024 Acadian Asset Management LLC318,536$998K0.0%N/A1.882% 8/5/2024 BBR Partners LLC10,000$31K0.0%N/A0.059% 8/1/2024 Rhumbline Advisers10,786$34K0.0%N/A0.064% 7/9/2024 Harbor Capital Advisors Inc.36,769$115K0.0%N/A0.217% (Data available from 1/1/2016 forward) MURA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of MURA shares? During the previous two years, 21 institutional investors and hedge funds held shares of Mural Oncology. The most heavily invested institutionals were Armistice Capital LLC ($5.30M), RBF Capital LLC ($1.13M), Verition Fund Management LLC ($1.06M), Acadian Asset Management LLC ($998K), Renaissance Technologies LLC ($729K), Centiva Capital LP ($638K), and Geode Capital Management LLC ($595K).Learn more on MURA's institutional investors. What percentage of Mural Oncology stock is owned by institutional investors? 80.21% of Mural Oncology stock is owned by institutional investors. Learn more on MURA's institutional investor holdings. Which institutional investors have been buying Mural Oncology stock? Of the 17 institutional investors that purchased Mural Oncology stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Armistice Capital LLC ($1.69M), Acadian Asset Management LLC ($318.54K), Primecap Management Co. CA ($235.55K), Renaissance Technologies LLC ($232.10K), Squarepoint Ops LLC ($167.64K), Point72 Asset Management L.P. ($108.72K), and Nicollet Investment Management Inc. ($98.02K). How much institutional buying is happening at Mural Oncology? Institutional investors have bought a total of 3,095,387 shares in the last 24 months. This purchase volume represents approximately $9.72M in transactions. Which Mural Oncology major shareholders have been selling company stock? The following institutional investors have sold Mural Oncology stock in the last 24 months: Verition Fund Management LLC ($170.85K), Primecap Management Co. CA ($95.51K), BNP Paribas Financial Markets ($68.69K), RBF Capital LLC ($28.23K), Centiva Capital LP ($20.83K), and Point72 Asia Singapore Pte. Ltd. ($14.07K). How much institutional selling is happening at Mural Oncology? Institutional investors have sold a total of 398,166 shares in the last 24 months. This volume of shares sold represents approximately $1.25M in transactions. Related Companies Zentalis Pharmaceuticals Institutional Ownership Amarin Institutional Ownership Genfit Institutional Ownership Trevi Therapeutics Institutional Ownership Solid Biosciences Institutional Ownership TScan Therapeutics Institutional Ownership Sutro Biopharma Institutional Ownership Lexeo Therapeutics Institutional Ownership Corbus Pharmaceuticals Institutional Ownership SOPHiA GENETICS Institutional Ownership This page (NASDAQ:MURA) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mural Oncology plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Mural Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
